Home LiteratureArticle Details
PMID: 18559575 Published · ppublish English Journal Article

Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program.

Clinical cancer research : an official journal of the American Association for Cancer Research ·Vol. 14 ·No. 12 ·2008-06-15 ·Pages 3643-5

Steeg PS

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/pharmacokinetics,therapeutic use Autopsy Biomarkers, Tumor/genetics,metabolism Breast Neoplasms/drug therapy,genetics,metabolism,pathology Drug Delivery Systems Female Gene Expression Regulation, Neoplastic/drug effects Genetic Heterogeneity/drug effects Humans Models, Biological Neoplasm Metastasis
Chemicals
Antineoplastic Agents Biomarkers, Tumor
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Steeg Patricia S
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. steegp@mail.nih.gov
References (20)
20 references, click to expand
  1. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications.
    Mol Oncol. 2007 Sep;1(2):172-80 PMID: 19383293
  2. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.
    Cancer Res. 2005 Oct 15;65(20):9155-8 PMID: 16230372
  3. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
    J Clin Oncol. 2008 Feb 20;26(6):983-94 PMID: 18281673
  4. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Coll Antropol. 2007 Dec;31(4):1043-7 PMID: 18217456
  5. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.
    Int J Cancer. 1995 Dec 11;63(6):790-3 PMID: 8847135
  6. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
    J Surg Oncol. 2003 Jun;83(2):85-93 PMID: 12772201
  7. No common denominator for breast cancer lymph node metastasis.
    Br J Cancer. 2005 Oct 17;93(8):924-32 PMID: 16189523
  8. Metastasis: a therapeutic target for cancer.
    Nat Clin Pract Oncol. 2008 Apr;5(4):206-19 PMID: 18253104
  9. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
    Oncol Rep. 2004 Apr;11(4):753-9 PMID: 15010868
  10. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
    Cancer. 2004 Mar 15;100(6):1110-22 PMID: 15022276
  11. Gene expression profiles of primary breast tumors maintained in distant metastases.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5 PMID: 14665696
  12. Breast cancer metastases are molecularly distinct from their primary tumors.
    Oncogene. 2008 Apr 3;27(15):2148-58 PMID: 17952122
  13. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
    J Clin Oncol. 1999 May;17(5):1474-81 PMID: 10334533
  14. Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes.
    Int J Clin Pract. 2005 Sep;59(9):1039-44 PMID: 16115179
  15. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
    J Clin Oncol. 2008 Mar 1;26(7):1059-65 PMID: 18227529
  16. Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.
    Oncologist. 2007 Jun;12(6):636-43 PMID: 17602055
  17. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
    Clin Cancer Res. 2008 Apr 1;14(7):1938-46 PMID: 18381931
  18. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Breast Cancer Res Treat. 2007 Jul;103(3):319-29 PMID: 17123152
  19. A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients.
    Int J Cancer. 2007 Sep 1;121(5):1036-46 PMID: 17450528
  20. In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells.
    Br J Cancer. 2001 Aug 3;85(3):431-8 PMID: 11487277
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
DOI
10.1158/1078-0432.CCR-08-1135
Email
steegp@mail.nih.gov
Published
2008-06-15
Pages
3643-5
Language
English
Region
United States
NLM ID
9502500
PMCID
PMC2692037
Subset
IM
Grants
Intramural NIH HHS · Z01 SC000892-24 · United States
External Links
PubMed source DOI: 10.1158/1078-0432.CCR-08-1135 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2